Priyanka Uniyal, Ph.D.

Ms. Priyanka Uniyal, Ph.D.


Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
2 October 2025 in Pharmaceuticals
Verified
Journal Article
Open access
PDF file
PPPriyanka Uniyal, Ph.D.
Priyanka Uniyal, Ph.D.
Ansab AkhtarAnsab Akhtar
Ansab Akhtar
RRRavi Rawat
Ravi Rawat
Cancer has remained a major global health challenge, with around 20 million new cases and 9.7 million fatalities recorded each year. Even though there has been recent progress in therapies such as radiotherapy, chemotherapy, immunotherapy, and gene therapy, cancer remains a major treatment challenge due to late diagnosis and difficulties in therapeutic effectiveness. Flavonoids, a substantial category of naturally occurring polyphenols, have received considerable interest in recent years for their potential involvement in cancer management and prevention, especially concerning breast cancer. These bioactive compounds, abundant in vegetables, fruits, and herbs, exhibit various therapeutic actions, including antioxidant, anti-inflammatory, and antimutagenic effects. The advanced therapeutic potential of flavonoids, when combined with FDA-approved medicines, offers synergistic effects and enhanced clinical results. Additionally, flavonoid-loaded nano-formulations, involving co-delivery systems, are being explored to increase solubility, stability, and bioavailability, enabling targeted delivery to cancer cells while reducing off-target adverse effects. This review examines the role of flavonoids in the prevention and management of breast cancer, focusing on their dietary sources, metabolism, and pharmacokinetic properties. Furthermore, we explore novel strategies, such as combination therapies with FDA-approved drugs and the application of flavonoid-based nanoformulations, which have the potential to enhance therapeutic outcomes. The clinical application of these strategies has the potential to improve breast cancer treatment and create new opportunities for the advancement of flavonoid-based therapies.

3 March 2023 in International Journal of Surgery
Verified
Journal Article
Open access
SMSumira Malik
Sumira Malik
ADArchna Dhasmana
Archna Dhasmana
JBJutishna Bora
Jutishna Bora
PPPriyanka Uniyal, Ph.D.
Priyanka Uniyal, Ph.D.
PSPetr Slama
Petr Slama
Kuldeep DhamaKuldeep Dhama
Kuldeep Dhama
An abstract is unavailable. This article is available as a PDF only.

1 March 2023 in International Journal of Surgery
Verified
Journal Article
Open access
SMSumira Malik
Sumira Malik
JBJutishna Bora
Jutishna Bora
ADArchna Dhasmana
Archna Dhasmana
SKShristi Kishore
Shristi Kishore
SAGNIK NAGSAGNIK NAG
SAGNIK NAG
Sarya SwedSarya Swed
Sarya Swed

9 July 2024 in PHYTONutrients
Verified
Journal Article
Open access
PDF file
MDMarco Dacrema
Marco Dacrema
HUHammad Ullah
Hammad Ullah
PPPriyanka Uniyal, Ph.D.
Priyanka Uniyal, Ph.D.
LLLorenza Francesca De Lellis
Lorenza Francesca De Lellis
DBDaniele Giuseppe Buccato
Daniele Giuseppe Buccato
Maria DagliaMaria Daglia
Maria Daglia
Baicalein (the aglycone of baicalin) is a trihydroxyflavone isolated from Scutellaria species, mainly Scutellaria baicalensis Georgi, which is used in Traditional Chinese Medicine to treat cold, hepatic and pulmonary diseases, insomnia, inflammation, hypertension, atherosclerosis, hyperlipidaemia, and dysentery. In scientific literature, baicalein has been extensively reported to exert in vitro and in vivo antioxidant and anti-inflammatory effects, as well as possessing anti-cancer, anti-microbial, immune-modulatory, metabolic, and cardiovascular protection properties. It may modulate a wide array of signaling pathways such as AMPK (5' adenosine monophosphate-activated protein kinase), PPAR-γ (Peroxisome proliferator-activated receptor gamma), Bcl-2 (B-cell lymphoma 2) and Bax (Bcl-2-associated X) proteins, CDKs (Cyclin-dependent kinases), MMP (metalloproteinases), SIRT1, NF-kB (nuclear factor kappa-light-chain-enhancer), EMT (epithelial–mesenchymal transition), TLRs (Toll-like receptors), CPT1 (carnitine palmitoyl transferase-1), and SREBP-1c (sterol regulation element binding response protein-1c). The present review is designed to focus on the potential bioactive activities of baicalein and/or baicalin.


1 February 2023 in International Journal of Surgery
Verified
Journal Article
Open access
SMSumira Malik
Sumira Malik
PPPriyanka Uniyal, Ph.D.
Priyanka Uniyal, Ph.D.
JBJutishna Bora
Jutishna Bora
Shafiul HaqueShafiul Haque
Shafiul Haque
Sarya SwedSarya Swed
Sarya Swed